Abstract
The development of clinical or practice guidelines is thought to be a successful strategy for improving quality of care. Accordingly, many professional organizations, societies, institutions of health care or policy, and even countries have published practice guidelines on a variety of topics, including heart failure.
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Heart Failure / drug therapy*
-
Heart Failure / physiopathology
-
Humans
-
Outcome Assessment, Health Care
-
Practice Guidelines as Topic*
-
Stroke Volume
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors